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Study Objectives: Coronary artery disease is considered to be the major cause of
death amongst patients with ischemic stroke. The coronary artery calcium (CAC) score is
related not only to sleep-disordered breathing, but also with future risk of cardiovascular
mortality. We investigated the association between the severity of sleep-disordered
breathing and CAC score in patients with ischemic stroke.
Methods: We included 32 patients who underwent coronary multichannel computed
tomography and polysomnography (within 2 years of the stroke event) amongst the
patients admitted to our clinic due to acute ischemic stroke. We investigated vascular
risk factors, polysomnography findings, and sleep questionnaire scores, and their
relationships with the CAC score.
Results: All patients were found to have sleep apnea of any degree, and 23 (72%) had
severe sleep apnea. Twenty-three (72%) patients had a positive CAC score. Higher CAC
scores were associated with elevated respiratory disturbance index (RDI), apnea index,
oxygen desaturation index, and STOP-BANG test scores. Multivariate analysis after
adjusting for potential confounding factors revealed independent relationships between
the CAC score and the RDI (ß [SE] = 5.3 [2.1], p = 0.01), oxygen desaturation index (ß
[SE] = 6.8 [2.8], p = 0.02), and STOP-BANG test score (ß [SE] = 90.3 [37.7], p = 0.02).
Conclusion: Our findings indicate a relationship between coronary atherosclerotic
burden measured by the CAC score and the severity of sleep apnea. Performing
polysomnography could be useful for investigating the severity of hidden coronary artery
disease among these patients.
BRIEF SUMMARY
Current Knowledge/Study Rationale: The effect of sleep apnea on coronary artery
disease in patients with ischemic stroke has not been explored. We investigated the
relationship between sleep apnea, its related characteristics and the coronary artery
calcium score in patients with stroke.
Study Impact: Our findings reveal a close relationship between the
atherosclerosis-related burden measured by the coronary artery calcium score
and the severity of sleep apnea that persisted after adjusting for confounding variables
related to the risk of coronary artery disease. Proper detection and treatment of sleep
apnea might mitigate the risk of future coronary events in patients with ischemic stroke.
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INTRODUCTION
Sleep apnea is a condition characterized by recurrent episodes of
airflow limitation during sleep resulting in frequent awakening,
hypoxia, and sympathetic activation (1). Sleep apnea can lead to a
decrease in the quality of life by causing impairments in daytime
alertness and cognitive function. Furthermore, individuals with
sleep apnea have been reported to show an increased risk of
cardiovascular diseases (2, 3).
Coronary artery occlusive disease (CAOD) is common in
patients with stroke (4). Previous studies have shown that 30–
70% patients with stroke are diagnosed with CAOD, which
is associated with long-term cardiovascular outcomes even
in patients without any definite clinical history of CAOD
(5, 6). Computed tomography-based coronary artery calcium
(CAC) score, a non-invasive and simple quantitative measure of
atherosclerotic burden in the coronary artery, can be used for the
prediction of occult coronary artery disease as a surrogate marker
for future cardiovascular events (7, 8). Given the association
between the risk of CAOD and prevalence of sleep apnea in an
otherwise healthy population (9), the atherosclerotic burden on
the coronary artery may be dependent on the severity of sleep
apnea in patients with stroke in whom sleep apnea is common.
However, this association has not been duly explored until now.
In the present study, we investigated the association between
the severity of sleep apnea, and the CAC score in patients with
ischemic stroke with no previous history of CAD.
MATERIALS AND METHODS
Study Population
This study was a retrospective observational study conducted
to investigate the relationship between atherosclerotic burden
and sleep disorder in patients with ischemic stroke or transient
ischemic attack (TIA). Cerebral infarction was confirmed with
brain imaging in patients with sudden and focal neurologic
deficits of a presumed vascular etiology. During hospitalization,
all the patients had undergone brain imaging studies, cerebral
angiographic studies, 12-lead electrocardiography, and standard
blood tests. Stroke management was per our stroke care pathway
based on the current guidelines for stroke care at our hospital.
Consecutive patients who (a) visited our stroke center within
7 days of an acute ischemic stroke or TIA, and (b) were admitted
to our stroke center during the study period and underwent
PSG between 2009 and 2016 were considered for eligibility in
this study. Prior to enrolling in this study, our neurologist
interviewed each patient to assess whether he/she experienced
any one of the Obstructive Sleep Apnea (OSA) symptoms such as
snoring, observed apnea, or excessive daytime sleepiness. When
the patient experienced two or more of the OSA symptoms,
polysomnography (PSG) was considered. The exclusion criteria
for our study were as follows: (1) age <40 years or more than
85 years; (2) definite history of coronary artery disease; (3) Body
Mass Index (BMI) more than 40 kg/m2; (4) significant bulbar
palsy requiring gastric tube or endotracheal tube insertion; (5)
patients who received thrombolytic or endovascular treatments;
(6) inadequate period of sleep (<2 h) during the PSG; and (7)
refusal to participate in the study. This study was approved
by the Severance Hospital Institutional Review Board. The
requirement for informed consent was waived because this study
was retrospective design and personal information was not used.
Coronary Artery Computed Tomography
Since July 2006, our stroke center has been using multi-detector
coronary computed tomography (MDCT) for detecting hidden
asymptomatic CAOD in patients with stroke (10). Briefly,MDCT
was consecutively performed when a patient had at least one of
the following: (1) presence of atherosclerosis in an intracranial
or extracranial cerebral artery; (2) presence of ≥2 risk factors for
coronary artery disease such as hypertension, diabetes mellitus,
dyslipidemia, cigarette smoking, and central obesity; and (3) old
age (males: >45 years, females: >55 years). MDCT was not
performed if patients had (1) known CAOD; (2) high pulse rates
that were not controlled with beta-blockers at the time of MDCT;
(3) poor cooperation; (4) impaired renal function; or (5) failure
to obtain informed consent from the patient.
In order to measure the CAC score, scanning was performed
with a dual-source CT scanner (Somatom Definition Flash;
Siemens Medical Solutions, Erlangen, Germany) using the
following parameters: prospective electrocardiographic gating,
120 kVp, 50mA; field-of-view, 18–20 cm; 0.33 s per rotation.
The CAC score (Agatston score) was calculated as the sum
of areas in the coronary artery with attenuation exceeding a
threshold of 130 HU with score weighting according to the
HU (11). In addition, the CAC volumes and CAC mass were
measured in the coronary arteries (12). CT coronary angiography
was performed after the administration of a non-ionic contrast
agent (Iopamiro) with retrospective electrocardiographic gating.
Stenosis was considered to be significant when there was more
than 50% narrowing in each of the four coronary arteries. The
CAC and the presence of significant stenosis in the coronary
arteries were reviewed by two cardiac radiologists.
Polysomnography and Sleep Pattern
Assessment
In-laboratory overnight sleep recording (Grass Technologies,
Twin PSG Software) was performed. The participants were
instructed to go to sleep in a dimly lit, temperature- and noise-
controlled sleep monitoring unit. The PSG recording included
electroencephalography using frontal, central, and occipital
electrodes; 1-lead electrocardiography; electromyography
on extraocular eye movement, chin, and bilateral anterior
tibialis muscles; nasal airflow and thermistor; peripheral
oxygen saturation; sleep position; and chest and abdominal
plethysmography. Sleep staging and respiratory- and movement-
scoring were done according to the American Academy of Sleep
Medicine manual (version 2.0) by a sleep technician with 10
years of experience (13). Based on the respiratory disturbance
index (RDI), we classified patients with RDI values between 5/h
and 30/h into the mild-to-moderate range for sleep apnea, and
patients with RDI values >30/h in the severe range for sleep
apnea. The oxygen desaturation index (ODI) was calculated as
the number of ≥4% desaturations divided by the total sleep time
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(in hours). The median days (range) from stroke to PSG were
10.0 days (0, 676).
Each subject was asked the questionnaires including the
Pittsburgh Sleep Quality Index (PSQI) (14) Beck Depression
Inventory (BDI) (15) Epworth Sleepiness Scale (ESS), and The
Snoring, Tiredness, Observed apnea, high blood Pressure-Body
mass index, Age, Neck circumference, and Gender (STOP-
BANG) score (16) to test the patients’ sleep habits and sleep-
related problems before the PSG.
Clinical Variables
We collected demographic information and data such as
body mass index and presence of vascular risk factors
such as hypertension, diabetes, dyslipidemia, and smoking
habits. Underlying cardiovascular diseases and concurrent use
of medications including hypnotics were also noted. Data
related to lipid profiles were also collected. Stroke severity
was assessed using the National Institutes of Health Stroke
Scale (NIHSS).
Statistical Analyses
Statistical analysis was performed using the Windows SPSS
package (version 23 IBM Corp., Armonk, NY, USA).
Comparisons of clinical variables, PSG findings, and CAC
scores between groups were made using the Wilcoxon Mann–
Whitney U-test for continuous variables and the Chi square
test for categorical variables, as appropriate. Spearman’s rank
correlation was used to identify relationships between CAC
measures and the continuous variables. Jonckheere’s trend test
was performed to compare the CAC scores between groups
TABLE 1 | Summary of baseline characteristics, polysomnographic findings, and sleep questionnaire scores.
All patients
(n = 32)
Mild-to-moderate sleep apnea
(n = 9)
Severe sleep apnea
(n = 23)
p-value
BASELINE CHARACTERISTICS AND VASCULAR RISK FACTORS
Age at stroke presentation (years) 64.0 (46–84) 55.0 (46–68) 66.0 (47–84) <0.01
Number of males, n (%) 26 (81%) 7 (78%) 19 (83%) >0.99
Body mass index§ (kg/m2) 24.4 (18.8–33.0) 22.5 (18.8–33.0) 24.6 (20.4–29.8) 0.08
Smoker, n (%) 9 (28%) 4 (44%) 5 (22%) 0.22
Diabetes Mellitus, n (%) 8 (25%) 1 (11%) 7 (30%) 0.38
Hypertension, n (%) 20 (63%) 4 (44%) 16 (70%) 0.24
Atrial fibrillation, n (%) 6 (19%) 1 (11%) 5 (22%) 0.64
Total cholesterol, mmol/L 4.4 (2.6–6.5) 4.9 (3.3–6.5) 3.9 (2.6–6.2) 0.04
Low density lipoprotein cholesterol, mmol/L 2.7 (1.2–4.7) 3.1 (1.8–4.0) 2.4 (1.2–4.7) 0.21
Triglyceride, mmol/L 1.2 (0.7–2.5) 1.2 (0.7–2.1) 1.1 (0.7–2.5) 0.93
High density lipoprotein cholesterol, mmol/L 1.1 (0.6–1.7) 1.2 (0.8–1.7) 1.0 (0.6–1.5) 0.38
NIHSS at stroke presentation 1.5 (0–16) 2.0 (0–6) 0 (0–16) 0.96
POLYSOMNOGRAPHY VARIABLES
Sleep efficiency, % 72.1 (24.4–92.4) 80.0 (64.0–92.4) 68.2 (24.4–91.3) 0.12
Sleep stage N1, % 41.8 (9.6–90.0) 25.7 (9.9–90.0) 42.6 (18.7–70.0) 0.08
Sleep stage N2, % 42.9 (10.1–71.5) 54.6 (10.1–71.5) 42.4 (16.6–64.3) 0.12
Sleep stage N3, % 0.0 (0.0–10.6) 0.0 (0.0–10.6) 0.0 (1.1) 0.20
Sleep stage R, % 13.3 (0–35.7) 13.9 (0.0–26.1) 12.2 (0.0–35.7) 0.90
Arousal index (events/hour) 53.0 (17.2–108.0) 35.0 (17.2–75.4) 62.8 (19.8–108.0) 0.02
PLMI (events/hour) 8.0 (0.0–96.2) 16.0 (0.0–58.7) 5.5 (0–96.2) 0.13
RDI (events/hour) 44.3 (5.1–109.2) 14.9 (5.1–28.0) 54.6 (31.2–109.2) <0.01
Apnea index (events/hour) 5.9 (0.0–62.7) 0 (0.0–5.3) 21.2 (0.0–62.7) <0.01
O2 desaturation index (events/hour) 17.7 (0.0–60.0) 6.0 (0.0–27.0) 35.5 (0.0–60.0) <0.01
Minimum O2 saturation (%) 81.2 (66.0–94.0) 86.8 (66.0–94.0) 79.0 (66.0– 88.0) 0.06
Average O2 saturation (%) 94.8 (87.9–97.5) 95.9 (93.4–97.5) 94.2 (87.9–95.9) <0.01
SLEEP QUESTIONNAIRE VARIABLES
PSQI 7.0 (1–13) 7.0 (1–10) 7.0 (2–13) 0.86
BDI 10.0 (0.0–23.0) 10.0 (3.0–21.0) 9.5 (0.0–23.0) 0.83
ESS 8.0 (0.0–17.0) 4.0 (0.0–17.0) 9.0 (0.0–17.0) 0.11
STOP-BANG 5.0 (2.0–7.0) 6.0 (2.0–6.0) 5.0 (2.0–7.0) 0.93
Presence of any CAOD (≥1 vessel) 13 (41%) 3 (33%) 10 (44%) 0.70
Data are presented as median (range) or number (percent). PLMI, Periodic limb movement index; RDI, Respiratory Disturbance Index; NIHSS, National Institutes of Health Stroke
Scale; PSQI, Pittsburgh Sleep Quality Index; BDI, Beck Depression Inventory; ESS, Epworth Sleepiness Scale; STOP-BANG, The Snoring, Tiredness, Observed apnea, high blood
Pressure-Body mass index, Age, Neck circumference, and Gender; CAOD, Coronary Artery Occlusive Disease. P < 0.05 was highlighted with bold characteristics.
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stratified by the severity of sleep apnea based on the RDI.
The effects of sleep-related variables on the CAC score were
determined using multiple linear regression analysis while
controlling for the effects of age, sex, BMI, and vascular
risk factors. The statistical significance threshold was set at
two-tailed p < 0.05.
RESULTS
Baseline Characteristics
During the study period, a total of 32 patients was included in
this study. The reason for relatively few patients included in
the study is explained in discussion section. Table 1 details the
baseline characteristics of the patients recruited in this study. The
mean age (±SD) of the study sample was 63.6 (±10.5) years,
and 26 (81%) patients were men. Hypertension was the most
common (63%, n = 20) vascular risk factor, followed by current
smoking (28%, n = 9), diabetes mellitus (25%, n = 8), and
hypercholesterolemia (9%, n= 3). Six patients reported a clinical
history of atrial fibrillation. Univariate analysis of coronary artery
calcium scores and clinical and sleep questionnaire variables is
shown in Supplementary Table 1.
PSG-Derived Parameters
All the patients had sleep apnea of some degree (mean RDI:
46.3/h ± 25.5/h; mild-to-moderate, n = 9; severe, n = 23).
Thirty (94%) patients had OSA based on the criteria listed
in the International Classification of Sleep Disorders, third
edition. Two patients were diagnosed with central sleep apnea
(central apnea index > 5/h and 50% of total RDI): one patient
had an overall RDI of 34.2/h (Cheyne-Stokes breathing and
concomitant congestive heart failure), while the other had
an RDI of 47.1/h (central sleep apnea syndrome after lateral
medullary infarction). The apnea index, ODI, and STOP-BANG
score were significantly higher in patients with severe sleep
apnea than in patients with mild-to-moderate sleep apnea, while
average O2 saturation was significantly lower in the former
(Table 1). Arousal index was higher in severe OSA group, while
periodic limbmovement index (PLMI) was not different between
the groups.
The Burden of CAC and Sleep-Disordered
Breathing
The mean (±SD) CAC score, CAC volume, and CAC mass
were 193.0 ± 274.1, 132.3 ± 194.5, and 25.5 ± 35.6,
respectively. Twenty-three (72%) patients had a positive CAC
score. When we categorized the study population into four
groups based on the quartiles of the RDI value, the CAC
score was observed to be higher in patients with higher RDI
values (Figure 1). Higher CAC scores were associated with
elevated RDI value, apnea index, ODI, and STOP-BANG score.
Arousal index and PLMI had no significant correlation with
CAC. On the other hand, the minimum oxygen saturation
was inversely correlated with the CAC score (Figure 2 and
Table 2). Linear regression analysis adjusting for the potential
determinants of the CAC score such as age, sex, body mass
index, total cholesterol, hypertension, diabetes mellitus, and
FIGURE 1 | Differences in coronary artery calcium scores by the respiratory
disturbance index quartiles.
smoking status revealed that the atherosclerotic burden as
measured by the CAC score was independently associated
with the RDI value (ß [SE] = 5.3 [2.1], p = 0.01), ODI
(ß [SE] = 6.8 [2.8], p = 0.02), and STOP-BANG score
(ß [SE] = 90.3 [37.7], p = 0.02), while there was no
statistically significant association between the CAC score and
the apnea index or the minimal and average O2 saturation
levels (Table 2).
Thirteen patients showed significant CAOD on ≥1 artery
(one vessel, n = 7; two vessels, n = 5; three vessels, n = 1) as
revealed by theMDCT.When the study population was classified
into two groups, namely patients with significant CAOD
(n = 13) and patients without significant CAOD (n = 19), no
group differences were observed in the baseline characteristics.
However, the total apnea index (any CAOD, 28.9 ± 24.0; no
CAOD, 8.7 ± 10.4; p = 0.01) and STOP-BANG score (any
CAOD, 5.9 ± 1.0; no CAOD, 4.3 ± 1.5; p = 0.001) were higher
in patients with significant CAOD than in patients without
significant CAOD.
Treatment
According to management guideline of OSA, we recommended
to all of subjects to use CPAP (continuous positive airway
pressure, including CSB and CSA patients, after in-lab pressure
titration), or APAP (automatic positive airway pressure) therapy.
As results, only 7 (22%) of OSA started receiving treatment. The
reason for not getting PAP treatment after PSG was as follows;
poor cooperation (n = 12), economic issues (n = 11), and need
for active rehabilitation of stroke sequalae (n = 2). Among 7
subjects who started PAP treatment, 4 are still using PAP therapy
with good compliance (follow-up years >2).
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FIGURE 2 | Correlation between the coronary calcium score and variables related to sleep-disordered breathing.
DISCUSSION
While the severity of sleep-disordered breathing has been
generally known to be correlated with systemic atherosclerosis
including CAOD, the significance of sleep apnea in patients
with stroke who are at high risk for future cardiovascular events
has not been duly recognized, given the lack of direct evidence
supporting it. Our findings indicate a strong association between
the severity of sleep apnea and the atherosclerotic burden as
measured by the CAC score. Furthermore, this association
remained significant after controlling for the effects of age, sex,
BMI, and other vascular risk factors.
There were two studies evaluating relationship between CAC
and OSA, in which subjects are people with non-symptomatic
CAD (17, 18). They commonly found correlation of OSA severity
and CAC. However, there are a few differences between our
finding and them. The work done in 2008 (17) set major
dependent variable as presence of CAC (binary variable, CAC
> 0 or not). This is because subjects having severe degree of
CAC were very few. In this study, even fourth high quartile
AHI (apnea-hyponea index) group had median of 44 agatson
score, which is much less than our result. Even more, in this
study, CAC did not correlate with O2 nadir. Instead of explaining
it with intermittent hypoxia which is generally accepted core
pathomechanism of atherosclerosis, they presumed that stressors
such as sleep time and frequent arousals might effect on CAC in
their subjects.
The other recent research paper (18) recruiting subjects
having health screenings, revealed only O2 nadir was
independently associated with CAC score. Although O2
nadir had trend for inverse relationship with CAC in our study,
the factors having independent association were RDI and ODI.
We assume that not O2 level itself, but frequency of desaturation
TABLE 2 | Multivariate analysis for determinants of the coronary artery calcium
scores.
ß (SE) P*
Sleep efficiency 4.1 (3.8) 0.29
Arousal index 3.0 (2.9) 0.31
RDI 5.3 (2.1) 0.01
Apnea index 5.3 (3.0) 0.08
O2 desaturation index 6.8 (2.8) 0.02
Minimum O2 saturation −16.1 (8.3) 0.06
Average O2 saturation −20.3 (33.8) 0.55
PSQI 28.0 (16.2) 0.09
BDI 3.2 (7.5) 0.67
ESS −4.3 (13.0) 0.74
STOP-BANG 90.3 (37.7) 0.02
*Adjusted for age, sex, bodymass index, total cholesterol, hypertension, diabetes mellitus,
and smoking status. RDI, Respiratory Disturbance Index; PSQI, Pittsburgh Sleep Quality
Index; BDI, Beck Depression Inventory; ESS, Epworth Sleepiness Scale; STOP-BANG,
The Snoring, Tiredness, Observed apnea, high blood Pressure-Body mass index, Age,
Neck circumference, and Gender. P < 0.05 was highlighted with bold characteristics.
event has much stronger factor for CAC, in our population.
Moreover, we also used structured questionnaire, consisting of
BDI, PSQI, ESS, and STOP-BANG. Among them, STOP-BANG
scale was independently associated with CAC after adjustment
for conventional vascular risk factors.
Detection of underlying CAD is essential because CAOD,
asymptomatic or symptomatic, is a strong predictor of future
cardiovascular events in patients with stroke (19). Previously, the
potential candidate for further CAD evaluation was primarily
based on the traditionally known vascular risk factors such
as hypertension, diabetes mellitus, dyslipidemia, or cigarette
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smoking, or the presence of concomitant cerebral atherosclerosis
(20, 21). Sleep apnea, a potential risk factor for CAD, could
be used for predicting the presence of hidden CAD. However,
previous studies have not investigated the relationship between
the CAC score and OSA (7, 8, 22). One study with a large
sample size examined the relationship between OSA and CAC
in otherwise healthy subjects, including individuals with obesity
(23). However, Korean patients with OSA or stroke are generally
not obese and that study did not evaluate patients with stroke.
In one study with the largest number of subjects, the presence
of OSA was based only on clinical symptoms (24) and not PSG
findings. In this study, we demonstrated an association between
the atherosclerotic burden measured by the CAC score and
the severity of OSA confirmed by PSG findings. Our results
emphasize the utility of PSG in determining the presence and
severity of sleep apnea and using it to identify hidden CAD
among patients with ischemic stroke.
Multiple pathophysiological mechanisms underlying the
relationship between sleep apnea and the development of
cardiovascular and cerebrovascular diseases have been proposed:
intermittent hypoxia, sympathetic activation, or inflammation
(25–27). Intermittent hypoxia, represented by RDI and ODI
in sleep apnea, is known to accentuate free radical production
and lipid oxidation (28, 29). A previous study showed that the
level of C-reactive protein, a reliable inflammatory marker, was
significantly higher in patients with OSA than in control subjects
(30). These detrimental effects of sleep apnea could result in
elevated atherosclerotic burden in patients with stroke with more
severe sleep apnea, as shown in this study.
Our study also found that the STOP-BANG score, primarily a
screening tool for diagnosing OSA, is independently associated
with the CAC score. This suggests that the use of a
simple questionnaire might be beneficial in the screening of
asymptomatic CAOD in patients with ischemic stroke. Although
we did not evaluate the relationship between biomarkers and
sleep apnea, the association between oxygen desaturation, ODI,
andCACdemonstrated in our study represents adverse biological
consequences of intermittent hypoxia on coronary artery health.
Recent large-scale trial examining the effectiveness of CPAP
therapy failed to prevent secondary coronary events in patients
with already established coronary artery disease (31), which
emphasize “primary” prevention of coronary events with CPAP
treatment. Also, the complex pathophysiology of OSA suggests
that new therapies or combination therapy might be more
effective than a CPAP therapy alone (32, 33).
Contrary to the previous findings (31, 34, 35) ESS was quite
low in this study. This may be explained in a few ways. In our
study population, Patients might had high level of anxiety for
stroke progression (in acute stage) and recurrence (in chronic
stage), combined unfamiliar situation with attached PSG device,
leading to “hyperarousal state” (36). BDI, used in our study,
has known to have significant relationship and overlap with
anxiety scales (37). It is also known that a person who has 13
or more BDI score are at risk for developing mood problem.
In our study, subjects with BDI>13 were ∼33%. Therefore, it
might be postulated that the patient with mood problem might
have reported low daytime sleepiness. Another previous study
suggested that there may be a relationship between lower ESS
and the severity of disability and the ESS is not a sensitive
marker of hypersomnolence or OSA in stroke patients (38).
Most of physical needs in stroke patients with disability are met
by hospital personnel or caregiver might result in less feeling
subjective sleepiness in these patients (38). In addition, the
use of drug having potential central stimulating effects such as
beta-blockers, statins, antithrombotics could the affect patients’
sleepiness level (39).
Recently published data showed short (<6 h) sleep duration
and frequent arousal is related with carotid and coronary
atherosclerosis (40, 41). However, we did not observe these
correlations. Possible cause is that most of our patients had
short total sleep time and high arousal index during PSG
(median and interquartile range of sleep time, 4.7 and 0.9 h;
arousal index, 53.9/h, 35.7, respectively). The two factors possibly
aggravated CAC, but both small sample size and relatively
homogenous characteristics (most were bad sleepers) might
make the statistical power decrease. Although not reached
the statistical significance (p = 0.21), another counterintuitive
finding is that higher sleep efficiency seemed to be related with
higher CAC (Figure 1). Similarly, the low sleep efficiency might
be related with shorter total sleep time in which respiratory events
are recorded sufficiently.
Interestingly, the apnea index value was not found to be
significantly associated with the CAC score in this analysis. This
finding was consistent even after removal of two CSA patients.
The lack of association between apnea index and CAC might
be ascribed to the fact that apnea events per se are far less
frequent than hypopnea and respiratory effort-related arousals.
The overall degree of oxygen desaturation and its frequency
showed stronger effects on the CAC score than apnea alone. We
did not find any significant difference in the values of the vascular
risk factors between groups assigned according to the CAC score,
although the proportion of each vascular risk factor tended to be
higher in patients with higher RDI values. Further, we found that
the sleep apnea-derived measures that could be confirmed by the
PSG study were significantly associated with the CAD burden.
This finding points to the superior potential of PSG in identifying
hidden CAD in patients with ischemic stroke compared to that of
conventional vascular risk factors (24).
The rate of receiving CPAP treatment was quite low. After
acute stage, the stroke patients usually were followed up by
stroke specialist, not a physician who cares sleep disorder.
Therefore, it is necessary to force them to visit regular to
recommend treatment repeatedly, even after initial denial for
receiving treatment.
The limitations of the current study must be addressed. First,
patients with high risk for OSA (having snoring, observed apnea,
or daytime sleepiness) and relatively mild stroke symptoms were
recruited in the study. Second, the sample size of our study
was not large enough for us to generalize our findings to the
wider population of patients with stroke. We also thought one
of limitations was low number of patients included in this study.
This was caused by patient’s refusal or reluctance to PSG due
to uncomfortable device, or unstable neurologic status within
acute stroke period, along with lack of personnel or PSG room
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availability. Actually, in previous studies of PSG for acute stroke
patients, the sample size was not large, which might be related
with some difficulties we also experienced. Furthermore, we
could not perform theMDCT for detecting hidden asymptomatic
CAOD coronary because of change in Korean government’s
insurance issue in a significant number of cases. These led in
small number of patients included in this study. Finally, long-
term prognosis including parameters such as number of future
cardiovascular events was not analyzed as a part of this study.
A follow-up study may be required to clarify the significance of
OSA in the presentation of cardiovascular outcomes.
CONCLUSIONS
Patients with ischemic stroke show significant sleep-disordered
breathing, such that higher severity of breathing distress is
associated with higher silent coronary artery atherosclerosis
burden. Given the relationship between sleep apnea and coronary
atherosclerosis, proper intervention and management of sleep
apnea might improve mortality outcomes among patients with
ischemic stroke.
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